Catalogo dei prodotti della ricerca

POCE, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.770
AS - Asia 3.693
EU - Europa 2.305
SA - Sud America 442
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 91
OC - Oceania 6
Totale 12.589
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.561
SG - Singapore 1.142
IT - Italia 1.056
CN - Cina 755
VN - Vietnam 553
HK - Hong Kong 552
BR - Brasile 338
IN - India 310
FI - Finlandia 225
DE - Germania 197
UA - Ucraina 142
FR - Francia 128
GB - Regno Unito 121
CA - Canada 117
SE - Svezia 115
BD - Bangladesh 102
RU - Federazione Russa 88
AR - Argentina 51
ID - Indonesia 40
ZA - Sudafrica 36
AT - Austria 35
IQ - Iraq 33
PL - Polonia 30
IE - Irlanda 28
JP - Giappone 27
BG - Bulgaria 26
KR - Corea 22
MX - Messico 22
TR - Turchia 22
CO - Colombia 19
TW - Taiwan 19
NL - Olanda 18
BE - Belgio 17
CR - Costa Rica 15
ES - Italia 15
RO - Romania 15
JM - Giamaica 13
MY - Malesia 13
PK - Pakistan 12
EC - Ecuador 11
MA - Marocco 11
SA - Arabia Saudita 11
NP - Nepal 10
PH - Filippine 10
VE - Venezuela 10
GT - Guatemala 9
AZ - Azerbaigian 8
HN - Honduras 8
IR - Iran 8
SN - Senegal 8
TH - Thailandia 8
EG - Egitto 7
KE - Kenya 7
AL - Albania 6
AU - Australia 6
JO - Giordania 6
NI - Nicaragua 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BB - Barbados 5
CZ - Repubblica Ceca 5
PY - Paraguay 5
CI - Costa d'Avorio 4
CL - Cile 4
LT - Lituania 4
LV - Lettonia 4
ME - Montenegro 4
SV - El Salvador 4
DZ - Algeria 3
EE - Estonia 3
SC - Seychelles 3
TG - Togo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NE - Niger 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
SI - Slovenia 2
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
Totale 12.296
Salva come PNG Salva come JPEG
Città #
Singapore 590
Hong Kong 539
Ashburn 503
San Jose 435
Fairfield 410
Rome 406
Chandler 289
Beijing 242
New York 241
Woodbridge 240
Milan 226
Houston 210
Santa Clara 191
Ho Chi Minh City 187
Seattle 179
Dallas 171
Ann Arbor 165
Cambridge 152
Wilmington 146
Hanoi 118
Los Angeles 116
Council Bluffs 114
Helsinki 104
Princeton 91
Buffalo 79
Plano 78
The Dalles 77
Lauterbourg 72
Boston 66
Frankfurt am Main 54
Jacksonville 51
San Paolo di Civitate 48
Phoenix 46
Munich 45
Toronto 42
Turku 40
Washington 40
Lawrence 39
San Diego 39
São Paulo 39
Figino 34
Ottawa 32
Boardman 29
Haiphong 29
Nuremberg 29
Redondo Beach 29
Andover 28
Dublin 28
Federal 27
Des Moines 26
Millbury 25
Falkenstein 24
Naples 24
Sofia 24
Tokyo 24
Chicago 22
Da Nang 22
Johannesburg 22
Shanghai 21
Vienna 20
Guangzhou 19
Jakarta 17
Norwalk 17
Brussels 16
Hefei 16
London 16
Warsaw 16
Brooklyn 15
Florence 15
Tianjin 15
Atlanta 14
Moscow 14
Orem 14
Pune 14
Taipei 13
Biên Hòa 12
Kolkata 12
Oxford 12
San José 12
Catania 11
Denver 11
Jinan 11
Kingston 11
La Puente 10
Medellín 10
Montreal 10
Rio de Janeiro 10
Frisco 9
Thái Bình 9
Turin 9
Baghdad 8
Dakar 8
Dhaka 8
Fuzhou 8
Hyderabad 8
Mumbai 8
Salt Lake City 8
Stockholm 8
Yubileyny 8
Amsterdam 7
Totale 7.908
Salva come PNG Salva come JPEG
Nome #
A novel antimycobacterial compound acts as an intracellular iron chelator 236
In vivo potent BM635 analogue with improved drug-like properties 208
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy 199
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis 195
Novel therapies for glaucoma: a patent review (2013-2019) 194
Activity of lipophilic and hydrophilic drugs against dormant and replicating mycobacterium tuberculosis 184
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents 183
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development 182
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? 176
Nano-based drug delivery systems of potent MmpL3 inhibitors for tuberculosis treatment 171
Direct-acting antivirals and host-targeting approaches against enterovirus B infections. Recent advances 169
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development 168
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 166
Antiviral mechanisms of N-phenyl benzamides on Coxsackie virus A9 165
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery 164
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation 164
Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach 162
Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class 160
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target 160
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212 159
COX inhibitors: a patent review (2011 - 2014) 157
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes 157
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects 155
1,5-Diphenyl Pyrrole Derivatives as Antimycobacterial Agents. Probing the Influence on Antimycobacterial Activity of Lipophilic Substituents at the Phenyl Rings 155
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection 150
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 149
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors 148
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 148
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 146
Novel pyrazole-containing compounds active against mycobacterium tuberculosis 142
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis 142
1,5-diarylpyrrole-3-acetic acids and esters as novel class of potent and selective COX-2 inhibitors. 140
MmpL3 is the flippase for mycolic acids in mycobacteria 140
C-9 Alkenylidine bridged macrolides: WO2008061189. 138
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 136
1,5-Diphenyl pyrroles as new antimycobacterial agents. Hit-to-lead development and target validation, New drugs for neglected diseases 132
Malaria transmission blocking compounds: a patent review 132
New 1,5-diarylpyrrole with improved antimycobacterial activity 131
Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography 129
1,5-DIARYLPYRROLE DERIVATIVESAS NOVEL CLASSES OF ACTIVE AND SELECTIVE COX-2 INHIBITORS. 129
SAR Analysis of Novel Coxsackie virus A9 Capsid Binders 128
1,5-Diaryl-Pyrroles as New Generation of Anti-Inflammatory and Analgesic Agents: Design, Synthesis, in vitro and in vivo Evaluation 128
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 128
New pyrroles with potential antimycobacterial, antifungal and COX-2 selective inhibiting activities. Synthetic methodologies 127
Antimycobacterial agents. Novel diarylpirrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity 125
Identification of a new chemical class of potent antimycobacterial compounds derived from BM 212: design, synthesis, biological evaluation and study of their mode of action. 124
Tannin microcapsules for synergy-enhanced sunscreen formulations 120
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents 120
New oxazolidinone derivatives as antibacterial agents with improved activity 119
New Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 117
Pyrrole Derivatives as New Antimycobacterial Class: Synthesis, S.A.R., Molecular Modelling Considerations and Microbiological Activity 116
Synthesis of new pyrrole derivatives of BM 212, a potent antimycobacterial compound 116
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 116
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitro-oxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 116
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis 116
HPLC Enantioseparation and Absolute Configuration of Novel Antiinflammatory Pyrrole Derivatives 113
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents 112
Analogs of BM 212: a new chemical class of antimycobacterial agents acting upon a new target 110
One-pot conversions of olefins to cyclic carbonates and secondary allylic and homoallylic amines to cyclic carbamates 108
Potent in vitro and in vivo novel 1,5-Diarylpyrrole-3-acetic Esters COX-2 inhibitors. 106
1,5-DIARYLPYRROLE-3-ACETIC ACIDS AND ESTERS AS NOVEL CLASSES OF POTENT AND SELECTIVE COX-2 INHIBITORS. 104
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 104
Novel inhibitors of Mycobacterium tuberculosis tryptophan biosynthetic pathway to treat tuberculosis 102
Development of MmpL3 inhibitors for tuberculosis treatment 101
BM212 targets MmpL3, Gordon Research Conference on Tuberculosis Drug Development 101
New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents. 99
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 98
Developing New Antiinflammatory and Analgesic Agents: Design, Synthesis, Biological and harmacological Evaluation 98
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment 98
New derivatives of BM 212 with improved antimycobacterial activity. 97
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 95
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 95
Pharmaceutical salt of BM635 with improved bioavailability 95
Overcoming drug resistance in TB: an update 95
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent 94
New Heterocyclic Compounds Targeting Trypanothyione Metabolism in Leishmania Parasites 93
Synthesis and biological evaluation of new heterocyclic derivatives with potential antimycobacterial activity: systematic approach to lead compound optimization 90
New 1,5-diphenyl pyrrole derived from BM 212: a new class of antimycobacterial Agents 90
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 88
Identification of a new Chemical Class of Potent Antimycobacterial Compounds 88
null 88
Doubly diastereoselective conjugate addition of enantiopure lithium amides to enantiopure N-enoyl oxazolidin-2-ones: a mechanistic probe 87
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 86
BM212 and new derivatives as a new class of antimycobacterial agents. 85
New 1,5 diarylpyrrole derivatives as antimycobacterial agents: Design, synthesis, biological evaluation and study of their mode of action 85
Design, synthesis and screening of new antitubercular agents derived from BM 212 83
Novel Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Anti-inflammatory and Analgesic Agents. Synthesis, in vitro and in vivo Biological Evaluation 83
ENANTIOMERS OF NOVEL ANTIINFLAMMATORY PYRROLE DERIVATIVES:ANALYTICAL AND SEMIPREPARATIVE HPLC SEPARATION AND CHIROPTICAL PROPERTIES. 82
Design and Synthesis of novel diarylpyrroles as p38 MAP kinase inhibitors 82
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials 81
New 1,5-diphenyl Pyrrole Derived from BM 212: a New class of Antimycobacterial Agents. 80
New heterocyclic compounds with potential activity against parasitic protozoan: Trypanosoma and Leishmania 80
In vivo screen of Plasmodium targets for mosquito-based malaria control 79
Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 79
Overcoming drug resistance for tuberculosis, 78
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action 73
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 72
New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation 69
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 66
Nuovi derivati 1,5-difenilpirrolici derivati del BM212 attivi come agenti antitubercolari 65
Totale 12.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022687 0 0 0 32 117 19 20 74 84 70 83 188
2022/2023948 190 188 21 88 92 99 25 65 81 39 45 15
2023/2024674 39 84 44 50 62 173 26 59 9 52 28 48
2024/20252.112 41 124 75 88 151 132 198 121 202 201 185 594
2025/20264.514 324 252 431 404 481 227 620 182 448 579 344 222
2026/20271.233 208 379 478 168 0 0 0 0 0 0 0 0
Totale 12.589